Carbonic Anhydrase Inhibitors rescue microvascular impairment and neuroinflammation in 3xTg AD mice
Elisa Canepa, Nicole L Lemon, Micaelly Alves, Rafael Vazquez‐Torres, Maryam H. Abyaneh, Silvia Fossati · 2025
Read Carbonic Anhydrase Inhibitors rescue microvascular impairment and neuroinflammation in 3xTg AD mice by Elisa Canepa, Nicole L Lemon, Micaelly Alves, Rafael Vazquez‐Torres, Maryam H. Abyaneh, Silvia Fossati (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709470.txt.
Description
Elisa Canepa and co-authors test two approved glaucoma drugs against Alzheimer's vessel damage in mice in a 2025 study. The disease harms the brain's small vessels early, feeding inflammation and the buildup of amyloid and tau. Carbonic anhydrase blockers had already rescued cells from amyloid toxicity in the team's earlier work.
In triple-transgenic Alzheimer's mice, the drugs improved microvascular function and calmed neuroinflammation, as the title reports. The mechanism work points at mitochondria, which amyloid disrupts in vessel and glia cells. Repurposing safe, known drugs for the vascular side of Alzheimer's could reach patients faster than new chemistry.
Catalog record
| CREATOR | Elisa Canepa, Nicole L Lemon, Micaelly Alves, Rafael Vazquez‐Torres, Maryam H. Abyaneh, Silvia Fossati |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |